EVEREST ORGANICS LTD. Share Price

EVEREST ORGANICS LTD. Share Price

BSE: 524790
|
Pharmaceuticals
₹ 290.00
-₹1.00 (-0.34%)
1D
Last updated 24 Jul, 2026, 15:14 IST

EVEREST ORGANICS LTD. Share Price Today

As of 25 Jul 2026, EVEREST ORGANICS LTD. share price is ₹290.00. The stock opened at ₹291.05, compared to its previous close of ₹291.00. During today's trading session, EVEREST ORGANICS LTD. share price moved in the range of ₹290.00 to ₹291.80, with an average price of ₹290.90 for the day. Looking at its last 52-week, the stock has touched a low of ₹197.00 and a high of ₹536.40.

₹290.00
0.34% down today
₹291.80
1D LOW
1D HIGH

EVEREST ORGANICS LTD. Returns Calculator

Circuit
L
H
₹232.80
₹349.20
52-week
L
H
₹197.00
₹536.40
Mkt Cap Cr
290.23
P/E
52.34
P/B
3.65
ROE
7.35%
D/E
0.66
ROCE
11.62%
Div. Yield
0.00%
EPS(TTM)
5.70
Turnover
2.24
EV/EBITDA
16.08
Net Margin
0.00%
Op. Margin
0.00%
ROA
2.32%
Quick Ratio
0.00
Curr. Ratio
1.53
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Everest Organics outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Everest Organics appears overvalued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,68,842.0036.735.0514.85%0.5518.72%18.850.91%0.5610.90
Divis Laboratories1,93,860.0061.369.4016.19%0.0021.00%9.430.50%0.5898.19
Torrent Pharmaceuticals1,92,687.0066.0317.0326.76%1.0518.30%16.900.90%0.4964.75
Cipla1,12,593.0033.553.2711.27%0.0014.95%423.360.93%0.4443.52
Zydus Lifesciences1,11,082.0017.393.2319.69%0.3520.30%3.700.11%0.3935.38
Lupin1,09,553.0019.834.7127.01%0.0327.44%3.510.78%0.61129.18
Mankind Pharma1,05,607.001.050.1212.65%0.4212.97%5.050.05%0.5449.37
Dr. Reddy's Laboratories97,364.9030.582.5611.07%0.1812.54%377.960.69%0.4138.68
Aurobindo Pharma88,508.4025.272.349.25%0.1911.76%391.140.26%0.4841.58
Laurus Labs84,727.3060.2610.1018.21%0.4516.70%10.190.20%0.9713.72

EVEREST ORGANICS LTD. Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹159.48₹197.24₹183.05₹200.05
Other Income₹0.69₹0.89₹6.94₹2.21
Total Revenue₹160.17₹198.13₹189.99₹202.26
Total Expenses₹163.41₹197.52₹189.90₹200.52
Profit Before Tax-₹3.24₹0.61₹0.09₹1.74
Tax-₹1.95₹0.47₹0.27₹0.60
Profit After Tax-₹1.29₹0.14-₹0.18₹1.14
EPS - Basic-₹2.97₹0.17-₹0.23₹1.43
EPS - Diluted-₹2.97₹0.17-₹0.23₹1.43

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax-₹3.24₹0.14-₹0.18₹1.14
Income before WC changes₹7.04₹10.79₹7.57₹7.87
Change in Assets₹6.23-₹17.50-₹14.43-₹29.64
Change in Liabilities-₹18.76₹23.13₹25.28₹35.51
Change in WC-₹12.53₹5.63₹10.85₹5.87
Cash flow from Operations-₹5.38₹16.42₹18.42₹13.74
Cash flow from Investing-₹5.17-₹13.32-₹15.60-₹16.82
Cash flow from Financing₹16.36-₹3.10-₹2.65₹2.07
Total Cash Flow₹5.82₹0.00₹0.18-₹1.01
Cash (Start of the year)₹0.27₹0.27₹0.65₹1.66
Cash (End of the year)₹6.09₹0.27₹0.83₹0.65

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹76.58₹76.74₹69.37₹60.12
Current Assets₹147.90₹149.98₹132.48₹117.88
Total Assets₹224.48₹226.72₹201.85₹178.00
Current Liabilities₹139.92₹160.10₹137.58₹112.56
Net Current Asset₹7.98-₹10.12-₹5.10₹5.32
Non-Current Liabilities₹14.61₹20.78₹18.05₹18.64
Equity Capital₹69.95₹45.84₹46.21₹46.80
Total Equity & Liabilities₹224.48₹226.72₹201.85₹178.00
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
290.35
20
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 20
Buy orders: 0%
Sell orders: 100%
Bearish
2
Neutral
4
Bullish
2
Neutral
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
49.72
Neutral
ATR (14)
23.01
Neutral
STOCH(9,6)
20.26
Bullish
STOCH RSI (14)
0
Bullish
ADX(9)
30.64
Bearish
UO(9)
43.03
Neutral
ROC(12)
-0.92
Bearish
WillR(14)
-76.36
Neutral
Period
Simple value
Exponential vaue
5D
300.29
297.44
10D
311.75
300.9
20D
293.12
295.23
50D
271.96
283.39
100D
270.82
295.2

About EVEREST ORGANICS LTD.

EVEREST ORGANICS LTD. Share Price
ISIN
INE334C01029
Sector Market Cap
₹ 290.23 Cr

Everest Organics Limited is engaged in the business of manufacturing of active pharmaceutical ingredients (API) and intermediaries. It is involved in the manufacturing of bulk drugs. The Company’s API products include Omeprazole, Pantoprazole Sodium Sesquihydrate, Esomeprazole Magnesium Trihydrate, Esomeprazole Magnesium Dihydrate, Esomeprazole Sodium, Omeprazole Sodium, Omeprazole Magnesium, Fenofibrate, Tamsulosin Hcl, and Dexlansoprazole. Its products under development include Remdesivir, Molnupiravir, Carbidopa, Acotiamide HCL, and Apixaban. Its intermediates products include Ethyl 2-(4-Hydroxyphenyl)-4-Methyl-5-Thiazolecarboxylate, Ethyl 2-(3-Formyl-4-Hydroxyphenyl)-4-Methylthiazole-5- Carboxylate, Ethyl 2-(3-Formyl-4-Isobutoxyphenyl)-4-Methylthiazole-5-Carboxylate, Ethyl 2-(3-Cyano-4-Isobutoxyphenyl)-4-Methyl-5- Thiazolecarboxylate, 2-Chloromethyl-4-Methoxy-3-Methyl-Pyridine Hydrochloride, and 5-(1H-Pyroll-1-yl)-2-Mercaptobenzimidazole, among others.

EVEREST ORGANICS LTD. Financial Highlights

  • Revenue: EVEREST ORGANICS LTD. reported revenue of ₹197.41 crore in FY26 vs ₹160.17 crore in FY25. It showed an increase of 23.25% on a yearly basis.
  • Operating Profit: EVEREST ORGANICS LTD. reported an operating profit of ₹8.05 crore in FY26 vs ₹3.24 crore in FY25. It showed an increase of 348.46% on a year-on-year basis.
  • Net Profit: EVEREST ORGANICS LTD. reported a net profit of ₹5.55 crore in FY26 vs ₹1.29 crore in FY25. It showed an increase of 530.23% on a yearly basis.

EVEREST ORGANICS LTD. Quarterly Result Highlights

  • EVEREST ORGANICS LTD. reported revenue of ₹48.91 crore in Mar 2026, compared with ₹42.84 crore in Dec 2025, representing an increase of 14.17% on a quarter-on-quarter (QoQ) basis.
  • EVEREST ORGANICS LTD. reported an operating profit of ₹2.17 crore in Mar 2026, compared with ₹1.04 crore in Dec 2025, representing an increase of 108.65% on a quarter-on-quarter (QoQ) basis.
  • EVEREST ORGANICS LTD. reported a profit of ₹2.63 crore in Mar 2026, compared with ₹0.36 crore in Dec 2025, reflecting an increase of 630.56% on a QoQ basis.
  • The earnings per share (EPS) of EVEREST ORGANICS LTD. stood at ₹2.97 during Mar 2026.
Know more
Promoters
59.60%
FII
0.00%
Other DII
0.02%
Retail and other
40.37%
Mutual funds
0.00%
Foreign institutions - FII
Compare against other stocks
EVEREST ORGANICS LTD. Share Price
EVEREST ORGANICS LTD.
Pharmaceuticals
Add Stock
Add Another

FAQs on EVEREST ORGANICS LTD. Share Price